The Multiplexed Diagnostics Market is forecasted to witness an Accelerate growth rate. The Incremental growth and the Accelerate growth momentum will encourage established as well as new vendors to make investments and strengthen their position in the Multiplexed Diagnostics Market.
The Multiplexed Diagnostics Market forecast has been derived by triangulating data from multiple sources and approaches. While arriving at the market size, we have considered data points, such as the size of the parent market and the revenues of key market participants, such as Agilent Technologies Inc., Becton, Dickinson and Co., bioMerieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Merck KGaA, QIAGEN NV, F. Hoffmann-La Roche Ltd., Siemens AG, and Thermo Fisher Scientific Inc..
